• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Akita Biosciences Launches to Pioneer Novel Intranasal Therapies

cafead

Administrator
Staff member
  • cafead   Oct 11, 2023 at 12:12: AM
via First product, Profi™, is a new once-daily nasal spray based on novel science from Boston's Brigham and Women's Hospital and used proactively to support respiratory wellness

article source